Report of Foreign Issuer (6-k)
November 19 2018 - 1:57PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 6-K
REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the
month of
November,
2018
.
Commission
File Number:
001-38524
Titan Medical Inc.
|
(Exact Name of Registrant as Specified in Charter)
|
|
170 University Avenue, Suite 1000
Toronto, Ontario M5H 3B3
Canada
|
(Address of principal executive offices)
|
Indicate by
check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form
20-F
⃞
Form 40-F
⊠
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1):_X__
Note
: Regulation S-T Rule 101(b)(1) only permits the submission
in paper of a Form 6-K if submitted solely to provide an attached annual
report to security holders.
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):___
Note
: Regulation S-T Rule 101(b)(7) only permits the submission
in paper of a Form 6-K if submitted to furnish a report or other
document that the registrant foreign private issuer must furnish and
make public under the laws of the jurisdiction in which the registrant
is incorporated, domiciled or legally organized (the registrant’s “home
country”), or under the rules of the home country exchange on which the
registrant’s securities are traded, as long as the report or other
document is not a press release, is not required to be and has not been
distributed to the registrant’s security holders, and, if discussing a
material event, has already been the subject of a Form 6-K submission or
other Commission filing on EDGAR.
SIGNATURE
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
|
|
TITAN MEDICAL INC.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
Date:
|
November 19, 2018
|
|
By:
|
/s/ Stephen Randall
|
|
|
|
|
Name:
|
Stephen Randall
|
|
|
|
Title:
|
Chief Financial Officer
|
EXHIBIT INDEX
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Sep 2023 to Sep 2024